"OPERATION RX" STING TARGETS 100 "ILLEGALLY DISTRIBUTED" HERBAL PRODUCTS
This article was originally published in The Tan Sheet
Executive Summary
"OPERATION RX" STING TARGETS 100 "ILLEGALLY DISTRIBUTED" HERBAL PRODUCTS, dietary supplements and drugs via 37 search warrants executed on May 12 by state and federal agents in seven states, FDA said. The probe, called "Operation Rx," is being coordinated by the U.S. Attorney's office in San Diego; 23 of the search warrants were served in California. No charges have been filed in relation to the investigation while the findings of the searches are being inventoried and documented. However, the California Food and Drug Branch said it expected the value of the seized drugs to be "in the millions of dollars." Undercover agents generated the list of 100 drug products for the search warrants. FDA said the two-year Operation Rx investigation is "ongoing" and "will continue for a lot longer." Further searches will be announced in the future, as will the results of the May 12 seizures. The 37 warrants alolowed for the search of 11 companies "and other places for evidence of wrongdoing" in seven states, the California Food and Drug Branch said. The businesses are Hospital Santa Monica, HSM Service Company, Pharmaceuticals International, International Pharmaceuticals, World Pharmaceuticals, Global Trading, Global Medical Information Services, Universal Metabolics, Universal Pharmaceuticals, Medigan, and Medicina Future. The search warrants for Operation Rx include charges of mail fraud, money laundering, smuggling, drug misbranding and introducing unapproved and misbranded drugs into interstate commerce. All of the 11 companies are suspected of being involved in dispensing prescription pharmaceuticals without prescriptions, principally by mail order. Other suspected activities include manufacturing unapproved drugs in the U.S. and importing unapproved drugs from Mexico and possibly other countries. Products listed in the warrants include shark cartilage, injectable selenium and hepamare caps, Essaic Tea liquid, Immu- Stim capsules, Hoxsey Herbal Therapy liquid and Retin-A ointment. Other products seized are frequently prescribed drugs such as Ciba-Geigy's Voltaren and SmithKline Beecham's Tagamet that were allegedly dispensed without prescriptions. Other drug products targeted by the search warrants were being sold under slightly modified brand names: for example, "Teldane" and "Seldene," apparently relabeled versions of Marion Merrell Dow's Seldane. The California Food and Drug Branch said that some of the targeted drugs "contain potent ingredients such as anabolic steroids, conjugated estrogens and the anticonvulsant phenytoin, that can cause harm if their use is not carefully monitored under medical supervision." Other drugs listed in the warrants contain unapproved ingredients or the anesthetic procaine instead of the labeled active ingredient. FDA issued a "Talk Paper" on May 12 advising that "consumers should avoid any drug supply source that offers to sell them prescription drugs without a prescription" and that any person purchasing drugs from the 11 listed companies "should consult their physicians." The agency said it "had to go public" with the findings due to the threat to consumer health. Other Operation Rx participants include the U.S. Customs Service, Internal Revenue Service, California Department of Justice, California Bureau of Narcotics and Enforcement, Florida Office of the State Prosecutor, Florida Department of Law Enforcement and Florida Department of Health and Rehabilitative Services. FDA has been active in cracking down on drug fraud recently. In March 1992, the San Diego U.S. Attorney's Office seized more than 15 tons of illegally imported "new-age" drug products from the "fountain of youth" drug import ring. Four months later, the Federal Bureau of Investigation arrested pharmacists nationwide as part of its "Operation Goldpill" drug probe.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning